Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
87 studies found for:    Alkermes
Show Display Options
Rank Status Study
1 Completed
Has Results
ALK21-010: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol-dependent Adults
Condition: Alcoholism
Interventions: Drug: Medisorb naltrexone 380 mg;   Drug: Medisorb naltrexone 190 mg
2 Completed
Has Results
ALK21-003EXT: An Extension of Study ALK21-003 (NCT01218958) to Test the Long-term Safety of Medisorb® Naltrexone (VIVITROL®)
Condition: Alcohol Dependence
Interventions: Drug: Medisorb naltrexone 190 mg;   Drug: Medisorb naltrexone 380 mg
3 Completed A Study of ALKS 8700, a Monomethyl Fumarate (MMF) Molecule, in Healthy Adults
Condition: Multiple Sclerosis
Interventions: Drug: Study Drug;   Drug: Active Control;   Drug: Placebo
4 Terminated
Has Results
ALK21-006EXT: Long-term Safety of Medisorb® Naltrexone (VIVITROL®) in Alcohol- or Opioid-dependent Adults (Extension of Study ALK21-006 [NCT01218997])
Conditions: Alcoholism;   Opiate Dependence
Interventions: Drug: Medisorb naltrexone 380 mg;   Drug: Oral naltrexone to Medisorb naltrexone 380 mg
5 Recruiting A Study of Aripiprazole Lauroxil (Also Known as ARISTADA TM) in Subjects With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: Aripiprazole Lauroxil
6 Completed A Study of the Abuse Liability Potential of Samidorphan in Healthy, Non-Dependent, Recreational Opioid Users
Condition: Healthy Volunteers
Interventions: Drug: Samidorphan;   Drug: Placebo;   Drug: Oxycodone
7 Completed A Study of the Abuse Liability Potential of ALKS 5461 in Healthy, Non-Dependent, Recreational Opioid Users
Condition: Healthy
Interventions: Drug: ALKS 5461;   Drug: Buprenorphine;   Drug: Placebo
8 Recruiting A Study of the Effects of ALKS 4230 on Subjects With Solid Tumors
Condition: Advanced Solid Tumors
Intervention: Drug: ALKS 4230
9 Completed A Phase 1 Safety Study in Adults With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: ALKS 3831
10 Completed A Drug-drug Interaction Study of ALKS 5461 in Healthy Volunteers
Condition: Healthy Volunteers
Intervention: Drug: ALKS 5461
11 Completed A Water Consumption Study of ALKS 5461 in Healthy Volunteers
Condition: Healthy
Intervention: Drug: ALKS 5461
12 Completed A Study of [14c]-Samidorphan (Also Known as ALKS 33) in Healthy, Male Volunteers
Condition: Healthy
Interventions: Drug: Samidorphan IV;   Drug: [14c]-Samidorphan sublingual;   Drug: [14c]-Samidorphan oral
13 Enrolling by invitation A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia
Condition: Schizophrenia
Intervention: Drug: ALKS 3831
14 Completed A Study to Evaluate the Effect of ALKS 5461 on QT Intervals in Healthy Volunteers
Condition: Healthy
Interventions: Drug: Moxifloxacin;   Drug: ALKS 5461;   Drug: Placebo
15 Completed Pharmacokinetics and Safety of ALKS 5461 in Subjects With Renal Impairment and Normal Renal Function
Condition: Renal Impairment
Intervention: Drug: ALKS 5461
16 Active, not recruiting A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use Disorder
Conditions: Schizophrenia;   Alcohol Use Disorder
Interventions: Drug: Samidorphan + olanzapine (ALKS 3831);   Drug: Placebo
17 Completed A Study of ALKS 3831 in Adults With Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Samidorphan (Low Dose);   Drug: Samidorphan (Medium Dose);   Drug: Samidorphan (High Dose);   Drug: Placebo;   Drug: Olanzapine
18 Completed ALK33BUP-101: Safety and Pharmacodynamic Effects of ALKS 33-BUP Administered Alone and When Co-administered With Cocaine
Condition: Cocaine Abuse
Interventions: Drug: ALKS 33-BUP;   Drug: ALKS 33;   Drug: Placebo
19 Recruiting An Insulin Sensitivity Study in Healthy Subjects
Condition: Healthy Volunteers
Interventions: Drug: ALKS 3831;   Drug: Olanzapine;   Drug: Placebo
20 Completed Pharmacokinetics and Safety of ALKS 5461 in Healthy Subjects and Subjects With Hepatic Impairment and Normal Hepatic Function
Condition: Hepatic Impairment
Intervention: Drug: ALKS 5461

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.